Unknown

Dataset Information

0

Equipment-free, salt-mediated immobilization of nucleic acids for nucleic acid lateral flow assays.


ABSTRACT: As the world has been facing several deadly virus crises, including Zika virus disease, Ebola virus disease, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and Coronavirus disease 2019 (COVID-19), lateral flow assays (LFAs), which require minimal equipment for point-of-care of viral infectious diseases, are garnering much attention. Accordingly, there is an increasing demand to reduce the time and cost required for manufacturing LFAs. The current study introduces an equipment-free method of salt-mediated immobilization of nucleic acids (SAIoNs) for LFAs. Compared to general DNA immobilization methods such as streptavidin-biotin, UV-irradiation, and heat treatment, our method does not require special equipment (e.g., centrifuge, UV-crosslinker, heating device); therefore, it can be applied in a resource-limited environment with reduced production costs. The immobilization process was streamlined and completed within 30 min. Our method improved the color intensity signal approximately 14 times compared to the method without using SAIoNs and exhibited reproducibility with the long-term storage stability. The proposed method can be used to detect practical targets (e.g., SARS-CoV-2) and facilitates highly sensitive and selective detection of target nucleic acids with multiplexing capability and without any cross-reactivity. This novel immobilization strategy provides a basis for easily and inexpensively developing nucleic acid LFAs combined with various types of nucleic acid amplification.

SUBMITTER: Park JS 

PROVIDER: S-EPMC9758654 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Equipment-free, salt-mediated immobilization of nucleic acids for nucleic acid lateral flow assays.

Park Jung Soo JS   Kim Seokjoon S   Han Jinjoo J   Kim Jung Ho JH   Park Ki Soo KS  

Sensors and actuators. B, Chemical 20211023


As the world has been facing several deadly virus crises, including Zika virus disease, Ebola virus disease, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and Coronavirus disease 2019 (COVID-19), lateral flow assays (LFAs), which require minimal equipment for point-of-care of viral infectious diseases, are garnering much attention. Accordingly, there is an increasing demand to reduce the time and cost required for manufacturing LFAs. The current study introdu  ...[more]

Similar Datasets

| S-EPMC10608873 | biostudies-literature
| S-EPMC9637530 | biostudies-literature
| S-EPMC7528719 | biostudies-literature
| S-EPMC4263543 | biostudies-literature
| S-EPMC4110901 | biostudies-literature
| S-EPMC1904290 | biostudies-literature
| S-EPMC10017168 | biostudies-literature
| S-EPMC8035659 | biostudies-literature
| S-EPMC8000918 | biostudies-literature
| S-EPMC5431006 | biostudies-literature